Package 27241-228-30

{"route": ["ORAL"], "spl_id": "b29a0bc6-2706-4a91-a4cb-d8f9a2dd94a0", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0327241228308", "0327241227301", "0327241230301", "0327241229305"], "unii": ["0H73WJJ391"], "rxcui": ["1436239", "1437278", "1437283", "1437288"], "spl_set_id": ["b94629e3-ae2e-473e-b2f5-06e32ee19aa9"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Ajanta Pharma USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-228-01)", "package_ndc": "27241-228-01", "marketing_start_date": "20230815"}, {"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-228-30)", "package_ndc": "27241-228-30", "marketing_start_date": "20230815"}], "brand_name": "Topiramate", "product_id": "27241-228_b29a0bc6-2706-4a91-a4cb-d8f9a2dd94a0", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "27241-228", "generic_name": "Topiramate", "labeler_name": "Ajanta Pharma USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "50 mg/1"}], "application_number": "ANDA215663", "marketing_category": "ANDA", "marketing_start_date": "20230815", "listing_expiration_date": "20271231"}